HUTCHMED (LON:HCM) Share Price Passes Below 200 Day Moving Average – Should You Sell?

HUTCHMED (China) Limited (LON:HCM)’s stock price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 262.99 ($3.34) and traded as low as GBX 255 ($3.23). HUTCHMED shares last traded at GBX 267 ($3.39), with a volume of 138,005 shares changing hands.

HUTCHMED Price Performance

The company has a fifty day simple moving average of GBX 232.45 and a 200-day simple moving average of GBX 262.99. The company has a market cap of £2.87 billion, a P/E ratio of -67.38 and a beta of 0.76. The company has a debt-to-equity ratio of 11.97, a current ratio of 2.81 and a quick ratio of 2.97.

HUTCHMED Company Profile

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S.

We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China.

HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange’s AIM market (Nasdaq/AIM:HCM; HKEX:13).